Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 313

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Donepezil Is Associated with Delayed Nursing Home Placement in Patients with Alzheimer's Disease

Geldmacher, David S., Provenzano, George, McRae, Thomas, Mastey, Vera, Ieni, John R. · 2003 · Journal of the American Geriatrics Society

Abstract

OBJECTIVES: To assess the relationship between donepezil treatment and time to nursing home placement (NHP) for patients with Alzheimer's disease (AD). DESIGN: Observational follow‐up of patient NHP and vital status. SETTING: Community. PARTICIPANTS: Patients previously enrolled in one of three randomized, double‐blind, placebo‐controlled clinical trials of donepezil and two subsequent open‐label studies (total N = 1,115); 671 patients provided complete data for analysis. MEASUREMENTS: Data were obtained through follow‐up interviews with caregivers and chart reviews of patients with AD. Comparison groups were defined by whether patients received an effective dose of donepezil (≥5 mg/d; ≥80% compliance) for specific numbers of weeks during the double‐blind or open‐label trial phase, in both phases, or in neither. Cox proportional hazards models were used to estimate risk ratios for NHP and survival curves from which median times to NHP were estimated for first dementia‐related placement of longer than 2 weeks and permanent placement. The models were adjusted for age, sex, baseline Mini‐Mental State Examination score, whether the caregiver was a spouse, caregiver continuity, and use of other cholinesterase inhibitors after the clinical trials. RESULTS: Use of donepezil of 5 mg/d or more was associated with significant delays in NHP. A cumulative dose‐response relationship was observed between longer‐term sustained donepezil use and delay of NHP. When donepezil was taken at an effective dose for at least 9 to 12 months, conservative estimates of the time gained before NHP were 21.4 months for first dementia‐related NHP and 17.5 months for permanent NHP. CONCLUSION: Use of donepezil by AD patients resulted in significant delays in NHP. Long‐term use of donepezil may help AD patients live longer in community settings, with consequent personal, social, and economic benefits.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2389.2003.51306.x

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 313

Metadata

Authors
Geldmacher, D. S., Provenzano, G., McRae, T., Mastey, V., & Ieni, J. R.
Venue
Journal of the American Geriatrics Society
Publisher
Wiley
Published
2003-07
Volume
51
Issue
7
Pages
937-944
ISSN
  • 0002-8614 (ISSN-L)
  • 1532-5415
OpenAlex
W2031709382
Cited by
313
References
31
FWCI
22.00
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Donepezil Is Associated with Delayed Nursing Home Placement in Patients with Alzheimer's Disease. https://app.cochat.ai/papers/10.1046/j.1365-2389.2003.51306.x
The paper
Geldmacher, D. S., Provenzano, G., McRae, T., Mastey, V., & Ieni, J. R. (2003). Donepezil Is Associated with Delayed Nursing Home Placement in Patients with Alzheimer's Disease. Journal of the American Geriatrics Society. https://doi.org/10.1046/j.1365-2389.2003.51306.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.